Cationic and Mesoionic 1,3-Thiazolo[3,2-c]quinazoline Derivatives 579
CH2Ph), 3.75–4.45 (m, 4H, CH2CHBrCH2Br), 4.58–
5.12 (m, 1H, CHBr), 7.35–8.65 (m, 9H, Ar H); MS
(70 eV): m/z (%) = 452 (M+ + 2) (7), 450 (M+) (4),
219 (100). Found: C, 47.94; H, 3.78; N, 6.49%. Calcd
for C18H16Br2N2S: C, 47.81; H, 3.57; N, 6.19%.
CH2 CH CH2), 5.70–6.50 (m, 1H, CH CH2), 7.30–
8.10 (m, 11H, Ar H); MS (70 eV): m/z (%) = 329
(M+ + 1) (12), 328 (M+) (41), 327 (100). Found: C,
76.77; H, 4.67; N, 8.66%. Calcd for C21H16N2S: C,
76.80; H, 4.91; N, 8.53%.
6b: Yield 0.47 g (40%), mp 128–130◦C, colorless
needles; IR (cm−1): 2935, 1618, 1585, 1565, 1542,
1530, 1450, 1401, 1342, 1318, 1250, 1170, 1082, 1030,
2-Bromomethyl-5-benzyl-, 5-(2-Chlorophenyl)-,
or 5-(2-Naphthyl)-2,3-dihydrothiazolo[3,2-c]-
quinazolin-4-ium bromide (8a–c)
1
871, 792, 735, 700; H NMR (CDCl3): ꢀ = 3.82–4.28
(m, 4H, CH2CHBrCH2Br), 4.45–4.95 (m, 1H, CHBr),
7.27–8.54 (m, 8H, Ar H); MS (70 eV): m/z (%) =
474 (M+ + 4) (4), 472 (M+ + 2) (8), 470 (M+) (5), 239
(100). Found: C, 43.42; H, 2.93; N, 5.79%. Calcd for
C17H13Br2ClN2S: C, 43.20; H, 2.77; N, 5.93%.
A solution of bromine (0.9 g, 5.6 mmol) in acetic acid
(15 ml) was added dropwise to a well-stirred solution
of the appropriate thione 7a–c (5 mmol) in the same
solvent (25 ml) at room temperature. The reaction
mixture was stirred at room temperature for 3 h and
the yellow solid which gradually separated during
the reaction was collected by filtration, washed with
water, and recrystallized from methanol to give 8a–c.
8a: Yield 1.5 g (67%), mp 238–240◦C, color-
less needles; IR (cm−1): 2954, 1618, 1590, 1560,
1480, 1350, 1300, 1245, 1029, 966, 825, 788, 727,
6c: Yield 0.53 g (44%), mp 134–136◦C, color-
less needles; IR (cm−1): 2970, 1625, 1560, 1540,
1501, 1456, 1349, 1262, 1160, 1020, 840, 780,
1
718, 685; H NMR (CDCl3): ꢀ = 3.66–4.37 (m, 4H,
CH2CHBrCH2Br), 4.45–4.82 (m, 1H, CHBr), 7.39–
8.66 (m, 11H, Ar H); MS (70 eV): m/z (%) = 488
(M+ + 2) (10), 486 (M+) (7), 255 (100). Found: C,
51.88; H, 3.60; N, 5.89%. Calcd for C21H16Br2N2S: C,
51.66; H, 3.30; N, 5.74%.
1
628; H NMR (CDCl3 + CF3CO2H): ꢀ = 3.36 (s, 2H,
CH2Ph), 3.68–4.18 (m, 2H, CH2Br), 4.95–5.70 (m, 3H,
N+ CH2 CH), 7.38–8.54 (m, 9H, Ar H); MS (70
eV): m/z (%) = 373 (M+ + 2) (6), 371 (M+) (7), 219
(100). Found: C, 47.90; H, 3.68; N, 6.25%. Calcd for
C18H16Br2N2S: C, 47.81; H, 3.57; N, 6.19%.
3-Allyl-2-benzyl-, 2-(2-Chlorophenyl)-,
or 2-(2-Naphthyl)-4(3H)-quinazolinethione
(7a–c)
8b: Yield 1.48 g (63%), mp 281–283◦C, colorless
needles; IR (cm−1): 2940, 1625, 1590, 1560, 1480,
1405, 1345, 1305, 1094, 1025, 826, 770, 728, 709;
1H NMR (CDCl3 + CF3CO2H): ꢀ = 3.78–4.26 (m, 2H,
CH2Br), 5.14–5.77 (m, 3H, N+ CH2 CH), 7.40–
8.56 (m, 8H, Ar H); MS (70 eV): m/z (%) = 393
(M+ + 2) (8), 391 (M+) (4), 239 (100). Found: C,
43.47; H, 2.84; N, 5.69%. Calcd for C17H13Br2ClN2S:
C, 43.20; H, 2.77; N, 5.93%.
To a suspension of the appropriate 1,3-benzothia-
zine-4(H)-thione 2a–c (8 mmol) in ethanol (50 ml),
allylamine (0.7 ml, 9.4 mmol) was added. The reac-
tion mixture was refluxed for 2 h. After cooling at
0◦C, the yellow precipitated solid was collected by
filtration and the crude product recrystallized from
ethanol to give 7a–c.
7a: Yield 1.8 g (77%), mp 110–112◦C, yellow
needles; IR (cm−1): 2965, 1575, 1520, 1470, 1350,
1330, 1210, 940, 910, 850, 760, 650; 1H NMR
(CDCl3): ꢀ = 3.38 (s, 2H, CH2Ph), 4.70–5.60 (m, 4H,
CH2 CH CH2), 5.90–6.50 (m, 1H, CH CH2), 7.18–
8.22 (m, 9H, Ar H); MS (70 eV): m/z (%) = 292 (M+)
(25), 219 (100). Found: C, 73.80; H, 5.58; N, 9.46%.
Calcd for C18H16N2S: C, 73.94; H, 5.52; N, 9.58%.
7b: Yield 2 g (80%), mp 115–117◦C, yellow nee-
dles; IR (cm−1): 1620, 1560, 1540, 1480, 1420, 1338,
1080, 1000, 990, 880, 790, 730, 690; 1H NMR (CDCl3):
ꢀ = 4.72–5.58 (m, 4H, CH2 CH CH2), 5.75–6.45 (m,
1H, CH CH2), 7.25–8.18 (m, 8H, Ar H); MS (70 eV):
m/z (%) = 314 (M+ + 2) (14), 313 (22), 312 (M+) (40),
297 (100). Found: C, 65.27; H, 4.25; N, 8.84%. Calcd
for C17H13ClN2S: C, 65.27; H, 4.19; N, 8.96%.
8c: Yield 1.58 g (65%), mp 225–227◦C, colorless
needles; IR (cm−1): 2928, 1615, 1557, 1522, 1478,
1404, 1346, 1255, 1178, 1020, 960, 842, 775, 740, 620;
1H NMR (CDCl3 + CF3CO2H): ꢀ = 3.75–4.15 (m, 2H,
CH2Br), 4.90–5.80 (m, 3H, N+ CH2 CH), 7.43–
8.70 (m, 11H, Ar H); MS (70 eV): m/z (%) = 409
(M+ + 2) (6), 407 (M+) (7), 255 (100). Found: C, 51.90;
H, 3.62; N, 5.84%. Calcd for C21H16Br2N2S: C, 51.66;
H, 3.30; N, 5.74%.
4-Carboxymethylthio-2-benzyl-, 2-(2-Chloro-
phenyl)-, or 2-(2-Naphthyl)quinazoline (9a–c)
Thiones 3a–c (4.5 mmol) and bromoacetic acid (0.63
g, 4.5 mmol) in anhydrous benzene (50 ml) were
treated with Et3N (0.64 ml, 4.6 mmol) and stirred
overnight at room temperature. The solution was fil-
tered to remove all Et3N·HBr, and the benzene was
evaporated in vacuo. The products 9a–c were finally
7c: Yield 2 g (77%), mp 127–129◦C, yellow
needles; IR (cm−1): 1618, 1570, 1557, 1470, 1365,
1342, 1210, 1118, 1030, 950, 912, 810, 762, 724,
620; 1H NMR (CDCl3): ꢀ = 4.75–5.52 (m, 4H,